ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.26
0.33%
US Tech 100
19,884.80
0.46%
S&P 500
5,631.22
0.28%
US Dollar vs CAD
1.36825
0.03%
Bitcoin
64,576.40
-0.41%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

NUWE

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
02/08/20244:19PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
02/06/20248:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
02/06/20248:00AMGlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
01/09/20244:30PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
01/08/20248:24AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
01/04/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
01/04/20242:05PMGlobeNewswire Inc.Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral CatheterNASDAQ:NUWENewellis Inc
12/13/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
11/28/20237:00AMGlobeNewswire Inc.New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric PatientsNASDAQ:NUWENewellis Inc
11/14/20233:30PMGlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
11/07/20239:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
11/07/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
11/07/20237:00AMGlobeNewswire Inc.Nuwellis, Inc. Announces Third Quarter 2023 Financial ResultsNASDAQ:NUWENewellis Inc
11/01/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
11/01/20237:00AMGlobeNewswire Inc.Nuwellis Announces Board of Directors TransitionNASDAQ:NUWENewellis Inc
10/31/20237:00AMGlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:NUWENewellis Inc
10/18/20233:15PMGlobeNewswire Inc.Nuwellis, Inc. To Announce Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:NUWENewellis Inc
10/17/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
10/17/20233:15PMGlobeNewswire Inc.Nuwellis Announces Closing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and WarrantsNASDAQ:NUWENewellis Inc
10/13/20237:30AMGlobeNewswire Inc.Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and WarrantsNASDAQ:NUWENewellis Inc
10/10/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
10/10/20237:00AMGlobeNewswire Inc.Nuwellis Provides Regulatory Update on SeaStar Medical’s Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:NUWENewellis Inc
10/06/20233:50PMEdgar (US Regulatory)Form POS462C - Post-effective amendment to registration statement [Rule 462(c)]NASDAQ:NUWENewellis Inc
10/05/20238:27AMEdgar (US Regulatory)Form AW - Amendment Withdrawal RequestNASDAQ:NUWENewellis Inc
10/04/20234:29PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NUWENewellis Inc
10/01/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NUWENewellis Inc
09/29/20237:56AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
09/11/20233:15PMGlobeNewswire Inc.Nuwellis to Present at the Gilmartin Group Emerging Growth ShowcaseNASDAQ:NUWENewellis Inc
09/06/20233:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
09/06/20233:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Your Recent History

USOTC
AXXA
Exxe (PK)
USOTC
MGON
Megola (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
IQST
iQSTEL (QX)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved